Tarsus Pharmaceuticals Inc (TARS)
36.19
+0.41
(+1.15%)
USD |
NASDAQ |
May 23, 16:00
36.19
0.00 (0.00%)
After-Hours: 17:18
Tarsus Pharmaceuticals Price to Book Value: 4.968 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 4.912 |
| May 21, 2024 | 5.193 |
| May 20, 2024 | 5.317 |
| May 17, 2024 | 5.250 |
| May 16, 2024 | 5.296 |
| May 15, 2024 | 5.285 |
| May 14, 2024 | 5.215 |
| May 13, 2024 | 5.268 |
| May 10, 2024 | 5.080 |
| May 09, 2024 | 4.673 |
| May 08, 2024 | 5.128 |
| May 07, 2024 | 5.221 |
| May 06, 2024 | 5.084 |
| May 03, 2024 | 5.059 |
| May 02, 2024 | 4.754 |
| May 01, 2024 | 4.460 |
| April 30, 2024 | 4.314 |
| April 29, 2024 | 4.409 |
| April 26, 2024 | 4.398 |
| April 25, 2024 | 4.421 |
| April 24, 2024 | 4.497 |
| April 23, 2024 | 4.627 |
| April 22, 2024 | 4.432 |
| April 19, 2024 | 4.453 |
| April 18, 2024 | 4.509 |
| Date | Value |
|---|---|
| April 17, 2024 | 4.725 |
| April 16, 2024 | 4.790 |
| April 15, 2024 | 4.796 |
| April 12, 2024 | 4.961 |
| April 11, 2024 | 5.252 |
| April 10, 2024 | 4.922 |
| April 09, 2024 | 4.974 |
| April 08, 2024 | 4.830 |
| April 05, 2024 | 4.765 |
| April 04, 2024 | 4.793 |
| April 03, 2024 | 4.922 |
| April 02, 2024 | 4.880 |
| April 01, 2024 | 4.917 |
| March 31, 2024 | |
| March 28, 2024 | 6.920 |
| March 27, 2024 | 6.581 |
| March 26, 2024 | 6.442 |
| March 25, 2024 | 6.488 |
| March 22, 2024 | 6.398 |
| March 21, 2024 | 6.408 |
| March 20, 2024 | 6.419 |
| March 19, 2024 | 6.000 |
| March 18, 2024 | 5.827 |
| March 15, 2024 | 6.012 |
| March 14, 2024 | 5.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.652
Minimum
Mar 24 2023
6.937
Maximum
Mar 06 2024
3.041
Average
2.684
Median
Price to Book Value Benchmarks
| Pacira BioSciences Inc | 1.584 |
| Unicycive Therapeutics Inc | -- |
| CEL-SCI Corp | 4.733 |
| AIM ImmunoTech Inc | 4.958 |
| IGC Pharma Inc | 3.439 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0804 |
| Price | 36.19 |
| Earnings Yield | -13.18% |
| Market Cap | 1.367B |
| PEGY Ratio | -0.0804 |